Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion type Assertion NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_head.
- NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion description "[The reason for this is thought to be that in cell lines of solid tumors the expression of cytidine deaminase, an enzyme that degrades cytarabine, is high, whereas the expression of deoxycytidine kinase (dCK), which phosphorylates cytarabine (a prodrug), is weak.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_provenance.
- NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion evidence source_evidence_literature NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_provenance.
- NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion SIO_000772 12049569 NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_provenance.
- NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion wasDerivedFrom befree-20150227 NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_provenance.
- NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_assertion wasGeneratedBy ECO_0000203 NP348342.RAUIO16UguwQj_mMfFwDPn_JuW_W9RV9zpIc8V__MMYVw130_provenance.